RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Summary
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 19, 2024
Last action Jan 24, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jan 24, 2024
Committee
Referred to HLT, CPC, referral sheet 2
lower
Jan 22, 2024
Introduced
Introduced and Pass First Reading.
lower
Jan 19, 2024
Introduced
Pending introduction.
lower
2 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Elijah Pierick
RRepublican
P
Natalia Hussey-Burdick
DDemocratic
Co
Amy Perruso
DDemocratic
Co
JK
Jeanné Kapela
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2024
Scope: HI
Hi! I can help you understand HB 2024. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline